Sales for Albemarle's Fine Chemicals segment were down 10% - to $146m - in Q4 2009 compared to 2008. The company has seen fine chemicals sales and profitability steadily increase over the past three quarters. Mark Rohr, Albemarle's Chairman, President and CEO, said the company was looking at a number of bolt-on acquisitions to continue growth, primarily in its fine chemicals business.
Seeking Alpha
Wednesday 27 January 2010
Albemarle fine chemicals sales decline
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment